PT3785702T - Citrato de vareniclina microparticulado - Google Patents

Citrato de vareniclina microparticulado

Info

Publication number
PT3785702T
PT3785702T PT201614765T PT20161476T PT3785702T PT 3785702 T PT3785702 T PT 3785702T PT 201614765 T PT201614765 T PT 201614765T PT 20161476 T PT20161476 T PT 20161476T PT 3785702 T PT3785702 T PT 3785702T
Authority
PT
Portugal
Prior art keywords
microparticulate
varenicline
citrate
varenicline citrate
microparticulate varenicline
Prior art date
Application number
PT201614765T
Other languages
English (en)
Original Assignee
Tiefenbacher Alfred E Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67137670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3785702(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tiefenbacher Alfred E Gmbh & Co Kg filed Critical Tiefenbacher Alfred E Gmbh & Co Kg
Publication of PT3785702T publication Critical patent/PT3785702T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT201614765T 2019-06-28 2020-03-06 Citrato de vareniclina microparticulado PT3785702T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19183309.4A EP3756653A1 (en) 2019-06-28 2019-06-28 Microparticulate varenicline citrate

Publications (1)

Publication Number Publication Date
PT3785702T true PT3785702T (pt) 2022-09-20

Family

ID=67137670

Family Applications (1)

Application Number Title Priority Date Filing Date
PT201614765T PT3785702T (pt) 2019-06-28 2020-03-06 Citrato de vareniclina microparticulado

Country Status (3)

Country Link
EP (2) EP3756653A1 (pt)
ES (1) ES2927460T3 (pt)
PT (1) PT3785702T (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240115109A (ko) * 2023-01-18 2024-07-25 주식회사 아울바이오 고용량 바레니클린을 포함하는 미립구 및 이의 제조방법 및 이를 포함하는 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010365A (es) 2001-05-14 2004-03-16 Pfizer Prod Inc Sal citrato de 5,7,14-triazatetraciclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma.
JP2019501207A (ja) * 2016-01-08 2019-01-17 シーティーシー バイオ,インコーポレイテッド バレニクリンまたはこの薬学的に許容可能な塩を含有する、味の遮蔽された口腔投与用薬学製剤

Also Published As

Publication number Publication date
EP3785702B1 (en) 2022-07-20
EP3785702A1 (en) 2021-03-03
EP3756653A1 (en) 2020-12-30
ES2927460T3 (es) 2022-11-07

Similar Documents

Publication Publication Date Title
IL273752A (en) Ingredients, compounds and methods for increasing cftr activity
EP3347870A4 (en) SAFE REAL-TIME REPLACEMENT OF ILLN
AU201816355S (en) Kettle
EP3624671A4 (en) BACKGROUND IMAGE CAPTURE
ZAA201801372S (en) Garlic press
EP3665718A4 (en) ARRANGEMENT FOR TREATMENT OF FLUX-FREE HOT WALL SOLDER BALLS
EP3718588C0 (en) CATHETER
EP3618723A4 (en) IMAGING CATHETER
GB201805095D0 (en) Compostion, method and use
EP3254800A4 (en) Flux activating agent, flux, and solder
PT3785702T (pt) Citrato de vareniclina microparticulado
GB2572366B (en) Imager
AU201812004S (en) Garlic presses
GB2559642B (en) Urgos kettle
PL4077261T3 (pl) Ko-sól cytrynianu i glicynianu magnezu
PL3369306T3 (pl) Prasa kostkująca
PL3369307T3 (pl) Prasa belująca
IL254075A (en) Pesticide Resistant Remedies
EP3616759A4 (en) ERGOMETER
GB2534899B (en) Double ended vascular filter.
EP3258957A4 (en) Polyelectrolyte multilayers assembled from immune signal compounds
Tucker MALD1_ResponseData. Rda
IL290663A (en) lead wire
IL283658A (en) The history of carboxylic acid, their preparation and their use
GB202011508D0 (en) .